Section 164.260 - Diversion ControlThe Licensed or Approved Provider shall maintain a diversion control plan using measures to reduce the possibility of diversion of controlled substances that are FDA-approved for the treatment of opioid dependency, which shall include:
(B) For patients who test positive for any FDA approved medications for treatment of opioid use disorder at admission, procedures for determining whether patients are enrolled in an opioid treatment program or are prescribed any medications for treatment of opioid use disorder, and documentation of actions taken in patient records;(C) Random drug screening; and(D) Initial and periodic review of patient's prescription history through the MassPAT.Adopted by Mass Register Issue 1482, eff. 11/11/2022.